Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma
Summary
Tune into our first episode in the Avalere Health Essential Voice series focused on disease education. In this segment, our experts discuss recent research that, using Medicare fee-for-service claims data, studied healthcare utilization, costs, outcomes, and other characteristics of patients who received CAR T-cell therapy for large B-cell lymphoma.To listen to this video as a podcast or read the transcript, please visit our podcast page.
Rare Disease Day Webinar: Voices that move systems
Access the webinar replay offering actionable, cross-geography insights on how patient and caregiver voices can improve diagnosis, engagement, and outcomes.
Replay

